Clinical and biochemical analysis of the prognostic relevance of biomarkers in multiple sclerosis

0044 English OPEN
Ingram, Gillian;
  • Subject: R1

The work in this thesis was initiated by the development of an extensive serum, plasma, cerebrospinal fluid (CSF) and deoxyribonucleic acid (DNA) multiple sclerosis (MS) disease and control biobank, with samples linked to extensive longitudinal clinical information. The... View more
  • References (17)
    17 references, page 1 of 2

    CHAPTER 6: ELEVATED PLASMA C4A LEVELS IN MULTIPLE SCLEROSIS CORRELATE WITH DISEASE ACTIVITY..............................................................................................................127 CHAPTER 9: INFLAMMATORY DISEASE ASSOCIATED COMPLEMENT POLYMORPHISMS DO NOT CONTRIBUTE TO DISEASE PHENOTYPE IN MULTIPLE SCLEROSIS........................................................................................................................................ 195 Abarrategui-Garrido, C., M. Melgosa, et al. (2008). "Mutations in proteins of the alternative pathway o f complement and the pathogenesis of atypical hemolytic uremic syndrome." Am J Kidnev P is 52(1): 171-80.

    Abou-Ragheb, H. H., A. J. Williams, et al. (1992). "Plasma levels o f the anaphylatoxins C3a and C4a in patients with IgA nephropathy/Henoch-Schonlein nephritis." Nephron 62(1): 22-6.

    Abrahamson, H. A. (1971). "Prevention o f experimental allergic encephalomyelitis with cobra venom factor." J Asthma Res 8(4): 151-2.

    Allison, R. S. and J. H. Millar (1954). "Prevalence o f disseminated sclerosis in Northern Ireland." Ulster Med J 23(Suppl. 2): 1-27.

    Amato, M. P. and N. De Stefano (2007). "Longitudinal follow-up o f "benign" multiple sclerosis at 20 years." Neurology 69(9): 938; author reply 938-9.

    Andersson, M., J. Alvarez-Cermeno, et al. (1994). "Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report." J Neurol Neurosurg Psychiatry 57(8): 897-902.

    Arumugam, T. V., I. A. Shiels, et al. (2004). "The role of the complement system in ischemia-reperfusion injury." Shock 21(5): 401-9.

    Arumugam, T. V., T. M. Woodruff, et al. (2009). "Neuroprotection in stroke by complement inhibition and immunoglobulin therapy." Neuroscience 158(3): 1074-89.

    Bakshi, R., M. Neema, et al. (2008). "Predicting clinical progression in multiple sclerosis with the magnetic resonance disease severity scale." Arch Neurol 65(11): 1449- 53.

    Bamer, A. M., K. Cetin, et al. (2007). "Comparing a self report questionnaire with physician assessment for determining multiple sclerosis clinical disease course: a validation study." Mult Scler 13(8): 1033-7.

  • Metrics
Share - Bookmark